跳到正文
ECA GMP News·AI 评分63

专家问答厘清审计追踪复核的执行部门与相关SOP制定职责

Responsibilities for the Audit Trail (Review)

AI 导读

六位制药行业与检查机构专家就现行欧盟GMP附录11的审计追踪要求作答,指出审计追踪通常由产生数据的部门(如QC或生产)复核,但不能由数据产生者本人完成,而由同事进行同级复核。

正文 · 原文

The requirements for an audit trail can be found in all relevant regulations. The changes and deletions of data, and in future also the creation of data, should be tracked in this way. In the new draft of the EU GMP guideline Annex 11, the requirements were described in much greater detail than before. 6 Experts from the pharmaceutical industry and from inspectorates answer an extensive list of questions in this context, focusing on the currently valid Annex 11. Question 10: Who is the process owner for the audit trail review? QA or the system owner?The audit trail is normally reviewed by the department that generated the data (e.g. in QC or production), but not by the same person who generated the data, i.e. by a colleague (peer review). The FDA's first Data Integrity Guidance still mentioned the Quality Unit (quality assurance) for this purpose; however, this was later changed to stipulate that a review must be carried out by a function with specialist knowledge. This view is also shared by all other guidelines. Question 11: Who is responsible for creating the specific audit trail review SOP? The process owner (e.g. the plant) or QA, and who must create an SOP for the general framework conditions of the audit trail review?To perform the audit trail review, an SOP is first required in which the risk assessment, the responsibilities for implementation and its frequency for the company are defined. This general SOP is usually created by the quality assurance department.To perform the audit trail review in a specific computer system (e.g. chromatography data system CDS), the data fields to be checked must be defined in a checklist. This checklist is developed by the specialist department that operates the system. Find more Q&As on the topic 'Audit Trail' which have been answered by the expert team. The Expert Team:Klaus Feuerhelm, Local GMP Inspectorate / Regierungspräsidium TübingenEberhard Kwiatkowski, PharmAdvantageIT, NeuschooDr Ullrich Opitz, Merck, DarmstadtYves Samson, Kereon, BaselDr Wolfgang Schumacher, ehem. F. Hoffmann-La Roche, BaselDr Arno Terhechte, Local GMP Inspectorate / Bezirksregierung Münster

来源:ECA GMP News · gmp-compliance.org